YZi Labs has expressed disappointment in CEA Industries’ adoption of a poison pill and charter amendments, alleging these actions undermine shareholders’ consent rights. The company, which directly owns 2,150,481 BNC shares, has filed a preliminary consent statement with the SEC to expand the board and elect its nominees. This escalation comes amid a broader governance dispute, following earlier criticisms over delayed annual meetings and the board’s response to shareholder actions.